ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Scopolamine Transdermal Patch Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-19G10308
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Scopolamine Transdermal Patch Market Insights Forecast to 2028
BUY CHAPTERS

Global Scopolamine Transdermal Patch Market Research Report 2025

Code: QYRE-Auto-19G10308
Report
July 2025
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Perrigo
Baxter
GSK
Mylan NV
Novartis
BengbuBBCATushan Pharmaceutical Co

Scopolamine Transdermal Patch Market Size

Global Scopolamine market is projected to reach US$ 15 million in 2029, increasing from US$ 11 million in 2022, with the CAGR of 4.2% during the period of 2023 to 2029.

Scopolamine Transdermal Patch Market

Scopolamine Transdermal Patch Market

The global market for Scopolamine Transdermal Patch was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Scopolamine is used to prevent nausea and vomiting caused by motion sickness or medications used during surgery. Scopolamine is in a class of medications called antimuscarinics. It works by blocking the effects of a certain natural substance (acetylcholine) on the central nervous system.
Demand from Tablets and Injection are the major drivers for the industry.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Scopolamine Transdermal Patch, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Scopolamine Transdermal Patch.
The Scopolamine Transdermal Patch market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Scopolamine Transdermal Patch market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Scopolamine Transdermal Patch manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Scopolamine Transdermal Patch Market Report

Report Metric Details
Report Name Scopolamine Transdermal Patch Market
Accounted market size in 2022 US$ 11 million
Forecasted market size in 2029 US$ 15 million
CAGR 4.2%
Base Year 2022
Forecasted years 2025 - 2029
Segment by Type
  • 1mg
  • 1.5mg
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Perrigo, Baxter, GSK, Mylan, Novartis, BengbuBBCATushan Pharmaceutical Co
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Scopolamine Transdermal Patch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Scopolamine Transdermal Patch in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Scopolamine Transdermal Patch Market growing?

Ans: The Scopolamine Transdermal Patch Market witnessing a CAGR of 4.2% during the forecast period 2025-2029.

What is the Scopolamine Transdermal Patch Market size in 2029?

Ans: The Scopolamine Transdermal Patch Market size in 2029 will be US$ 15 million.

Who are the main players in the Scopolamine Transdermal Patch Market report?

Ans: The main players in the Scopolamine Transdermal Patch Market are Perrigo, Baxter, GSK, Mylan, Novartis, BengbuBBCATushan Pharmaceutical Co

What are the Application segmentation covered in the Scopolamine Transdermal Patch Market report?

Ans: The Applications covered in the Scopolamine Transdermal Patch Market report are Motion Sickness, Nausea/Vomiting, Parkinsonian Tremor, Others

What are the Type segmentation covered in the Scopolamine Transdermal Patch Market report?

Ans: The Types covered in the Scopolamine Transdermal Patch Market report are 1mg, 1.5mg

Recommended Reports

Transdermal Patches

Skin & Dermal Care

Drug Delivery Systems

1 Scopolamine Transdermal Patch Market Overview
1.1 Product Definition
1.2 Scopolamine Transdermal Patch by Type
1.2.1 Global Scopolamine Transdermal Patch Market Value Comparison by Type (2024 VS 2031)
1.2.2 1mg
1.2.3 1.5mg
1.3 Scopolamine Transdermal Patch by Application
1.3.1 Global Scopolamine Transdermal Patch Market Value by Application (2024 VS 2031)
1.3.2 Motion Sickness
1.3.3 Nausea/Vomiting
1.3.4 Parkinsonian Tremor
1.3.5 Others
1.4 Global Scopolamine Transdermal Patch Market Size Estimates and Forecasts
1.4.1 Global Scopolamine Transdermal Patch Revenue 2020-2031
1.4.2 Global Scopolamine Transdermal Patch Sales 2020-2031
1.4.3 Global Scopolamine Transdermal Patch Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Scopolamine Transdermal Patch Market Competition by Manufacturers
2.1 Global Scopolamine Transdermal Patch Sales Market Share by Manufacturers (2020-2025)
2.2 Global Scopolamine Transdermal Patch Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Scopolamine Transdermal Patch Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Scopolamine Transdermal Patch, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Scopolamine Transdermal Patch, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Scopolamine Transdermal Patch, Product Type & Application
2.7 Global Key Manufacturers of Scopolamine Transdermal Patch, Date of Enter into This Industry
2.8 Global Scopolamine Transdermal Patch Market Competitive Situation and Trends
2.8.1 Global Scopolamine Transdermal Patch Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Scopolamine Transdermal Patch Players Market Share by Revenue
2.8.3 Global Scopolamine Transdermal Patch Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Scopolamine Transdermal Patch Market Scenario by Region
3.1 Global Scopolamine Transdermal Patch Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Scopolamine Transdermal Patch Sales by Region: 2020-2031
3.2.1 Global Scopolamine Transdermal Patch Sales by Region: 2020-2025
3.2.2 Global Scopolamine Transdermal Patch Sales by Region: 2026-2031
3.3 Global Scopolamine Transdermal Patch Revenue by Region: 2020-2031
3.3.1 Global Scopolamine Transdermal Patch Revenue by Region: 2020-2025
3.3.2 Global Scopolamine Transdermal Patch Revenue by Region: 2026-2031
3.4 North America Scopolamine Transdermal Patch Market Facts & Figures by Country
3.4.1 North America Scopolamine Transdermal Patch Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Scopolamine Transdermal Patch Sales by Country (2020-2031)
3.4.3 North America Scopolamine Transdermal Patch Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Scopolamine Transdermal Patch Market Facts & Figures by Country
3.5.1 Europe Scopolamine Transdermal Patch Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Scopolamine Transdermal Patch Sales by Country (2020-2031)
3.5.3 Europe Scopolamine Transdermal Patch Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Scopolamine Transdermal Patch Market Facts & Figures by Region
3.6.1 Asia Pacific Scopolamine Transdermal Patch Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Scopolamine Transdermal Patch Sales by Region (2020-2031)
3.6.3 Asia Pacific Scopolamine Transdermal Patch Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Scopolamine Transdermal Patch Market Facts & Figures by Country
3.7.1 Latin America Scopolamine Transdermal Patch Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Scopolamine Transdermal Patch Sales by Country (2020-2031)
3.7.3 Latin America Scopolamine Transdermal Patch Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Scopolamine Transdermal Patch Market Facts & Figures by Country
3.8.1 Middle East and Africa Scopolamine Transdermal Patch Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Scopolamine Transdermal Patch Sales by Country (2020-2031)
3.8.3 Middle East and Africa Scopolamine Transdermal Patch Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Scopolamine Transdermal Patch Sales by Type (2020-2031)
4.1.1 Global Scopolamine Transdermal Patch Sales by Type (2020-2025)
4.1.2 Global Scopolamine Transdermal Patch Sales by Type (2026-2031)
4.1.3 Global Scopolamine Transdermal Patch Sales Market Share by Type (2020-2031)
4.2 Global Scopolamine Transdermal Patch Revenue by Type (2020-2031)
4.2.1 Global Scopolamine Transdermal Patch Revenue by Type (2020-2025)
4.2.2 Global Scopolamine Transdermal Patch Revenue by Type (2026-2031)
4.2.3 Global Scopolamine Transdermal Patch Revenue Market Share by Type (2020-2031)
4.3 Global Scopolamine Transdermal Patch Price by Type (2020-2031)
5 Segment by Application
5.1 Global Scopolamine Transdermal Patch Sales by Application (2020-2031)
5.1.1 Global Scopolamine Transdermal Patch Sales by Application (2020-2025)
5.1.2 Global Scopolamine Transdermal Patch Sales by Application (2026-2031)
5.1.3 Global Scopolamine Transdermal Patch Sales Market Share by Application (2020-2031)
5.2 Global Scopolamine Transdermal Patch Revenue by Application (2020-2031)
5.2.1 Global Scopolamine Transdermal Patch Revenue by Application (2020-2025)
5.2.2 Global Scopolamine Transdermal Patch Revenue by Application (2026-2031)
5.2.3 Global Scopolamine Transdermal Patch Revenue Market Share by Application (2020-2031)
5.3 Global Scopolamine Transdermal Patch Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Perrigo
6.1.1 Perrigo Company Information
6.1.2 Perrigo Description and Business Overview
6.1.3 Perrigo Scopolamine Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Perrigo Scopolamine Transdermal Patch Product Portfolio
6.1.5 Perrigo Recent Developments/Updates
6.2 Baxter
6.2.1 Baxter Company Information
6.2.2 Baxter Description and Business Overview
6.2.3 Baxter Scopolamine Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Baxter Scopolamine Transdermal Patch Product Portfolio
6.2.5 Baxter Recent Developments/Updates
6.3 GSK
6.3.1 GSK Company Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Scopolamine Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.3.4 GSK Scopolamine Transdermal Patch Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 Mylan
6.4.1 Mylan Company Information
6.4.2 Mylan Description and Business Overview
6.4.3 Mylan Scopolamine Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Mylan Scopolamine Transdermal Patch Product Portfolio
6.4.5 Mylan Recent Developments/Updates
6.5 Novartis
6.5.1 Novartis Company Information
6.5.2 Novartis Description and Business Overview
6.5.3 Novartis Scopolamine Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Novartis Scopolamine Transdermal Patch Product Portfolio
6.5.5 Novartis Recent Developments/Updates
6.6 BengbuBBCATushan Pharmaceutical Co
6.6.1 BengbuBBCATushan Pharmaceutical Co Company Information
6.6.2 BengbuBBCATushan Pharmaceutical Co Description and Business Overview
6.6.3 BengbuBBCATushan Pharmaceutical Co Scopolamine Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.6.4 BengbuBBCATushan Pharmaceutical Co Scopolamine Transdermal Patch Product Portfolio
6.6.5 BengbuBBCATushan Pharmaceutical Co Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Scopolamine Transdermal Patch Industry Chain Analysis
7.2 Scopolamine Transdermal Patch Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Scopolamine Transdermal Patch Production Mode & Process Analysis
7.4 Scopolamine Transdermal Patch Sales and Marketing
7.4.1 Scopolamine Transdermal Patch Sales Channels
7.4.2 Scopolamine Transdermal Patch Distributors
7.5 Scopolamine Transdermal Patch Customer Analysis
8 Scopolamine Transdermal Patch Market Dynamics
8.1 Scopolamine Transdermal Patch Industry Trends
8.2 Scopolamine Transdermal Patch Market Drivers
8.3 Scopolamine Transdermal Patch Market Challenges
8.4 Scopolamine Transdermal Patch Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Perrigo
Baxter
GSK
Mylan NV
Novartis
BengbuBBCATushan Pharmaceutical Co
List of Tables
 Table 1. Global Scopolamine Transdermal Patch Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Scopolamine Transdermal Patch Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Scopolamine Transdermal Patch Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Scopolamine Transdermal Patch Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Scopolamine Transdermal Patch Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Scopolamine Transdermal Patch Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Scopolamine Transdermal Patch Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Scopolamine Transdermal Patch Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Scopolamine Transdermal Patch, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Scopolamine Transdermal Patch, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Scopolamine Transdermal Patch, Product Type & Application
 Table 12. Global Key Manufacturers of Scopolamine Transdermal Patch, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Scopolamine Transdermal Patch by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Scopolamine Transdermal Patch as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Scopolamine Transdermal Patch Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Scopolamine Transdermal Patch Sales by Region (2020-2025) & (K Units)
 Table 18. Global Scopolamine Transdermal Patch Sales Market Share by Region (2020-2025)
 Table 19. Global Scopolamine Transdermal Patch Sales by Region (2026-2031) & (K Units)
 Table 20. Global Scopolamine Transdermal Patch Sales Market Share by Region (2026-2031)
 Table 21. Global Scopolamine Transdermal Patch Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Scopolamine Transdermal Patch Revenue Market Share by Region (2020-2025)
 Table 23. Global Scopolamine Transdermal Patch Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Scopolamine Transdermal Patch Revenue Market Share by Region (2026-2031)
 Table 25. North America Scopolamine Transdermal Patch Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Scopolamine Transdermal Patch Sales by Country (2020-2025) & (K Units)
 Table 27. North America Scopolamine Transdermal Patch Sales by Country (2026-2031) & (K Units)
 Table 28. North America Scopolamine Transdermal Patch Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Scopolamine Transdermal Patch Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Scopolamine Transdermal Patch Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Scopolamine Transdermal Patch Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Scopolamine Transdermal Patch Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Scopolamine Transdermal Patch Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Scopolamine Transdermal Patch Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Scopolamine Transdermal Patch Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Scopolamine Transdermal Patch Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Scopolamine Transdermal Patch Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Scopolamine Transdermal Patch Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Scopolamine Transdermal Patch Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Scopolamine Transdermal Patch Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Scopolamine Transdermal Patch Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Scopolamine Transdermal Patch Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Scopolamine Transdermal Patch Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Scopolamine Transdermal Patch Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Scopolamine Transdermal Patch Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Scopolamine Transdermal Patch Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Scopolamine Transdermal Patch Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Scopolamine Transdermal Patch Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Scopolamine Transdermal Patch Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Scopolamine Transdermal Patch Sales (K Units) by Type (2020-2025)
 Table 51. Global Scopolamine Transdermal Patch Sales (K Units) by Type (2026-2031)
 Table 52. Global Scopolamine Transdermal Patch Sales Market Share by Type (2020-2025)
 Table 53. Global Scopolamine Transdermal Patch Sales Market Share by Type (2026-2031)
 Table 54. Global Scopolamine Transdermal Patch Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Scopolamine Transdermal Patch Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Scopolamine Transdermal Patch Revenue Market Share by Type (2020-2025)
 Table 57. Global Scopolamine Transdermal Patch Revenue Market Share by Type (2026-2031)
 Table 58. Global Scopolamine Transdermal Patch Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Scopolamine Transdermal Patch Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Scopolamine Transdermal Patch Sales (K Units) by Application (2020-2025)
 Table 61. Global Scopolamine Transdermal Patch Sales (K Units) by Application (2026-2031)
 Table 62. Global Scopolamine Transdermal Patch Sales Market Share by Application (2020-2025)
 Table 63. Global Scopolamine Transdermal Patch Sales Market Share by Application (2026-2031)
 Table 64. Global Scopolamine Transdermal Patch Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Scopolamine Transdermal Patch Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Scopolamine Transdermal Patch Revenue Market Share by Application (2020-2025)
 Table 67. Global Scopolamine Transdermal Patch Revenue Market Share by Application (2026-2031)
 Table 68. Global Scopolamine Transdermal Patch Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Scopolamine Transdermal Patch Price (US$/Unit) by Application (2026-2031)
 Table 70. Perrigo Company Information
 Table 71. Perrigo Description and Business Overview
 Table 72. Perrigo Scopolamine Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Perrigo Scopolamine Transdermal Patch Product
 Table 74. Perrigo Recent Developments/Updates
 Table 75. Baxter Company Information
 Table 76. Baxter Description and Business Overview
 Table 77. Baxter Scopolamine Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Baxter Scopolamine Transdermal Patch Product
 Table 79. Baxter Recent Developments/Updates
 Table 80. GSK Company Information
 Table 81. GSK Description and Business Overview
 Table 82. GSK Scopolamine Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. GSK Scopolamine Transdermal Patch Product
 Table 84. GSK Recent Developments/Updates
 Table 85. Mylan Company Information
 Table 86. Mylan Description and Business Overview
 Table 87. Mylan Scopolamine Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Mylan Scopolamine Transdermal Patch Product
 Table 89. Mylan Recent Developments/Updates
 Table 90. Novartis Company Information
 Table 91. Novartis Description and Business Overview
 Table 92. Novartis Scopolamine Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Novartis Scopolamine Transdermal Patch Product
 Table 94. Novartis Recent Developments/Updates
 Table 95. BengbuBBCATushan Pharmaceutical Co Company Information
 Table 96. BengbuBBCATushan Pharmaceutical Co Description and Business Overview
 Table 97. BengbuBBCATushan Pharmaceutical Co Scopolamine Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. BengbuBBCATushan Pharmaceutical Co Scopolamine Transdermal Patch Product
 Table 99. BengbuBBCATushan Pharmaceutical Co Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. Scopolamine Transdermal Patch Distributors List
 Table 103. Scopolamine Transdermal Patch Customers List
 Table 104. Scopolamine Transdermal Patch Market Trends
 Table 105. Scopolamine Transdermal Patch Market Drivers
 Table 106. Scopolamine Transdermal Patch Market Challenges
 Table 107. Scopolamine Transdermal Patch Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Scopolamine Transdermal Patch
 Figure 2. Global Scopolamine Transdermal Patch Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Scopolamine Transdermal Patch Market Share by Type: 2024 & 2031
 Figure 4. 1mg Product Picture
 Figure 5. 1.5mg Product Picture
 Figure 6. Global Scopolamine Transdermal Patch Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Scopolamine Transdermal Patch Market Share by Application: 2024 & 2031
 Figure 8. Motion Sickness
 Figure 9. Nausea/Vomiting
 Figure 10. Parkinsonian Tremor
 Figure 11. Others
 Figure 12. Global Scopolamine Transdermal Patch Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Scopolamine Transdermal Patch Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Scopolamine Transdermal Patch Sales (2020-2031) & (K Units)
 Figure 15. Global Scopolamine Transdermal Patch Average Price (US$/Unit) & (2020-2031)
 Figure 16. Scopolamine Transdermal Patch Report Years Considered
 Figure 17. Scopolamine Transdermal Patch Sales Share by Manufacturers in 2024
 Figure 18. Global Scopolamine Transdermal Patch Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Scopolamine Transdermal Patch Players: Market Share by Revenue in Scopolamine Transdermal Patch in 2024
 Figure 20. Scopolamine Transdermal Patch Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Scopolamine Transdermal Patch Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Scopolamine Transdermal Patch Sales Market Share by Country (2020-2031)
 Figure 23. North America Scopolamine Transdermal Patch Revenue Market Share by Country (2020-2031)
 Figure 24. United States Scopolamine Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Scopolamine Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Scopolamine Transdermal Patch Sales Market Share by Country (2020-2031)
 Figure 27. Europe Scopolamine Transdermal Patch Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Scopolamine Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Scopolamine Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Scopolamine Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Scopolamine Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Scopolamine Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Scopolamine Transdermal Patch Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Scopolamine Transdermal Patch Revenue Market Share by Region (2020-2031)
 Figure 35. China Scopolamine Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Scopolamine Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Scopolamine Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Scopolamine Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Scopolamine Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Scopolamine Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Scopolamine Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Scopolamine Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Scopolamine Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Scopolamine Transdermal Patch Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Scopolamine Transdermal Patch Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Scopolamine Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Scopolamine Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Scopolamine Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Scopolamine Transdermal Patch Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Scopolamine Transdermal Patch Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Scopolamine Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Scopolamine Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Scopolamine Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Scopolamine Transdermal Patch by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Scopolamine Transdermal Patch by Type (2020-2031)
 Figure 56. Global Scopolamine Transdermal Patch Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Scopolamine Transdermal Patch by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Scopolamine Transdermal Patch by Application (2020-2031)
 Figure 59. Global Scopolamine Transdermal Patch Price (US$/Unit) by Application (2020-2031)
 Figure 60. Scopolamine Transdermal Patch Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Transdermal Scopolamine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Transdermal Medical Patch Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Scopolamine Market Insights Forecast to 2030
OTC Transdermal Analgesic Patches Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Nicotine Transdermal Patches Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Transdermal Analgesic Patch Market Research Report 2024
Global Transdermal Absorption Patch Market Research Report 2025
Global Transdermal Transmission Patches Market Research Report 2024
Transdermal Nicotine Patch Market
Rivastigmine Transdermal Patches Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Medical Transdermal Patch Market Research Report 2025
Global Transdermal Skin Patch Market Research Report 2025
Global Transdermal Skin Patches Market Research Report 2024
Medical Wearable Patches Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Transdermal Therapeutic Systems TTS Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Contraceptive Transdermal Patche Market Research Report 2024
Microneedle Drug Delivery Patches Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Transdermal Drug Delivery Formulation Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Medical Antipyretic Patch Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Patch Type Medical Skin Dressing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19B19893
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30B3636
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3H1702
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13C3384
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions